309 related articles for article (PubMed ID: 21235378)
21. Elevated serum matrix metalloprotease (MMP-2) as a candidate biomarker for stable COPD.
Mahor D; Kumari V; Vashisht K; Galgalekar R; Samarth RM; Mishra PK; Banerjee N; Dixit R; Saluja R; De S; Pandey KC
BMC Pulm Med; 2020 Nov; 20(1):302. PubMed ID: 33198714
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores.
von Nussbaum F; Li VM
Bioorg Med Chem Lett; 2015 Oct; 25(20):4370-81. PubMed ID: 26358162
[TBL] [Abstract][Full Text] [Related]
23. The neutrophil in chronic obstructive pulmonary disease.
Hoenderdos K; Condliffe A
Am J Respir Cell Mol Biol; 2013 May; 48(5):531-9. PubMed ID: 23328639
[TBL] [Abstract][Full Text] [Related]
24. New drugs under development for COPD.
Lo Bello F; Hansbro PM; Donovan C; Coppolino I; Mumby S; Adcock IM; Caramori G
Expert Opin Emerg Drugs; 2020 Dec; 25(4):419-431. PubMed ID: 32882146
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticosteroids differentially regulate MMP-9 and neutrophil elastase in COPD.
Vlahos R; Wark PA; Anderson GP; Bozinovski S
PLoS One; 2012; 7(3):e33277. PubMed ID: 22413009
[TBL] [Abstract][Full Text] [Related]
26. Natural compounds as inhibitors of human neutrophil elastase.
Siedle B; Hrenn A; Merfort I
Planta Med; 2007 May; 73(5):401-20. PubMed ID: 17447201
[TBL] [Abstract][Full Text] [Related]
27. Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis.
Elborn JS; Perrett J; Forsman-Semb K; Marks-Konczalik J; Gunawardena K; Entwistle N
Eur Respir J; 2012 Oct; 40(4):969-76. PubMed ID: 22267768
[TBL] [Abstract][Full Text] [Related]
28. The role of neutrophils in cystic fibrosis.
Gifford AM; Chalmers JD
Curr Opin Hematol; 2014 Jan; 21(1):16-22. PubMed ID: 24253427
[TBL] [Abstract][Full Text] [Related]
29. Progranulin is a substrate for neutrophil-elastase and proteinase-3 in the airway and its concentration correlates with mediators of airway inflammation in COPD.
Ungurs MJ; Sinden NJ; Stockley RA
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L80-7. PubMed ID: 24186875
[TBL] [Abstract][Full Text] [Related]
30. New approaches to the management of COPD.
Stockley RA
Chest; 2000 Feb; 117(2 Suppl):58S-62S. PubMed ID: 10673477
[TBL] [Abstract][Full Text] [Related]
31. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
32. Clickable 4-Oxo-β-lactam-Based Selective Probing for Human Neutrophil Elastase Related Proteomes.
Ruivo EF; Gonçalves LM; Carvalho LA; Guedes RC; Hofbauer S; Brito JA; Archer M; Moreira R; Lucas SD
ChemMedChem; 2016 Sep; 11(18):2037-42. PubMed ID: 27465595
[TBL] [Abstract][Full Text] [Related]
33. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
34. Secretory leukocyte protease inhibitor in cystic fibrosis.
Stromatt SC
Agents Actions Suppl; 1993; 42():103-10. PubMed ID: 8102834
[TBL] [Abstract][Full Text] [Related]
35. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.
Bchir S; Nasr HB; Bouchet S; Benzarti M; Garrouch A; Tabka Z; Susin S; Chahed K; Bauvois B
J Cell Mol Med; 2017 Jul; 21(7):1280-1291. PubMed ID: 28004483
[TBL] [Abstract][Full Text] [Related]
36. Synergistic cycles of protease activity and inflammation via PPARγ degradation in chronic obstructive pulmonary disease.
Kwak N; Lee KH; Woo J; Kim J; Lee CH; Yoo CG
Exp Mol Med; 2021 May; 53(5):947-955. PubMed ID: 34021254
[TBL] [Abstract][Full Text] [Related]
37. Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview.
Marinaccio L; Stefanucci A; Scioli G; Della Valle A; Zengin G; Cichelli A; Mollica A
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328340
[TBL] [Abstract][Full Text] [Related]
38. Treatment options for moderate-to-very severe chronic obstructive pulmonary disease.
Cazzola M; Rogliani P; Ora J; Matera MG
Expert Opin Pharmacother; 2016; 17(7):977-88. PubMed ID: 26894516
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis.
Stockley R; De Soyza A; Gunawardena K; Perrett J; Forsman-Semb K; Entwistle N; Snell N
Respir Med; 2013 Apr; 107(4):524-33. PubMed ID: 23433769
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium.
Hiemstra PS; van Wetering S; Stolk J
Eur Respir J; 1998 Nov; 12(5):1200-8. PubMed ID: 9864022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
